About the Authors
- Etienne Levavasseur
-
Affiliation INSERM, Avenir Team - Human Prion Diseases, Paris, France
- Isabelle Laffont-Proust
-
Affiliation INSERM, Avenir Team - Human Prion Diseases, Paris, France
- Émilie Morain
-
Affiliation INSERM, Avenir Team - Human Prion Diseases, Paris, France
- Baptiste A. Faucheux
-
Affiliations INSERM, Avenir Team - Human Prion Diseases, Paris, France, APHP, R. Escourolle Neuropathology Laboratory, Paris, France
- Nicolas Privat
-
Affiliation INSERM, Avenir Team - Human Prion Diseases, Paris, France
- Katell Peoc'h
-
Affiliation Biochemistry and Molecular Biology Department, Lariboisière Hospital, Paris, France
- Véronique Sazdovitch
-
Affiliations INSERM, Avenir Team - Human Prion Diseases, Paris, France, APHP, R. Escourolle Neuropathology Laboratory, Paris, France
- Jean-Philippe Brandel
-
Affiliation INSERM, Avenir Team - Human Prion Diseases, Paris, France
- Jean-Jacques Hauw
-
Affiliations APHP, R. Escourolle Neuropathology Laboratory, Paris, France, InVS, French National Center of Reference for Unconventional Transmissible Agents, Paris, France
- Stéphane Haïk
-
* E-mail: haik@chups.jussieu.fr
Affiliations INSERM, Avenir Team - Human Prion Diseases, Paris, France, APHP, R. Escourolle Neuropathology Laboratory, Paris, France, InVS, French National Center of Reference for Unconventional Transmissible Agents, Paris, France
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: EL ILP SH. Performed the experiments: EL ILP M KP. Analyzed the data: EL ILP BF JJH SH. Contributed reagents/materials/analysis tools: NP KP VS JPB JJH SH. Wrote the paper: EL ILP BF KP JPB JJH SH.